GlassScriptPhysician profile
Allison A Bannick
NPI 1821103441
$61,673.59
in general payments reported to CMS, 2019-2025
7 companies · $9,464 in 2025
The $9,464 reported for 2025 was more than what 99% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,134 · 2022: $8,404 · 2023: $27K · 2024: $15K · 2025: $9,464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Travel and Lodging: $15K · Consulting Fee: $4,236 · Food and Beverage: $2,991 · Honoraria: $1,890.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,200.00 |
| Travel and Lodging | $14,819.68 |
| Consulting Fee | $4,236.00 |
| Food and Beverage | $2,990.62 |
| Honoraria | $1,890.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomarin Pharmaceutical INC. | $45,967.17 | 2021-2025 | Palynziq, Kuvan |
| Genzyme Corporation | $8,240.07 | 2022-2024 | |
| Horizon Therapeutics Plc | $6,370.20 | 2022-2023 | Ravicti |
| Eton Pharmaceuticals, INC. | $1,000.00 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.62 | 2022-2023 | Vpriv |
| Ultragenyx Pharmaceutical INC. | $30.00 | 2021 | |
| Electromed, INC. | $21.53 | 2025 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Bannick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.